Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Azam

Blood

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Blood|February 17, 2022
PLaCatinG AML1-ETOMohammad Azam
Blood|January 28, 2009
ICSBP-mediated immune protection against BCR-ABL-induced leukemia requires the CCL6 and CCL9 chemokinesValentina Nardi, Olaia Naveiras, Mohammad Azam, et al.
Blood|May 31, 2007
Farnesyl transferase inhibitor resistance probed by target mutagenesisTal Raz, Valentina Nardi, Mohammad Azam, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Blood|February 17, 2022
PLaCatinG AML1-ETOMohammad Azam
Blood|January 28, 2009
ICSBP-mediated immune protection against BCR-ABL-induced leukemia requires the CCL6 and CCL9 chemokinesValentina Nardi, Olaia Naveiras, Mohammad Azam, et al.
Blood|May 31, 2007
Farnesyl transferase inhibitor resistance probed by target mutagenesisTal Raz, Valentina Nardi, Mohammad Azam, et al.
Pageof 1